AstraZeneca’s Vaccine Trial Paused After Suspected Adverse Reaction
Late-stage trials of one of the front-running coronavirus vaccine candidates are on hold after a serious illness from one participant, Stat first reported. AstraZeneca said the “standard review process triggered a pause to vaccination to allow review of safety data.”